What can narcolepsy teach us about hypocretin and dementia?

Authors

Renata K Carvalho, Tathiana A Alvarenga, Fernando M S Coelho, Sergio Tufik, Monica L Andersen

Published in

Ageing research reviews. Pages 103388. Oct 02, 2026. Epub Oct 02, 2026.

Abstract

Sleep and circadian disturbances are associated with cognitive decline and dementia. Narcolepsy type 1 (NT1), characterized by severe sleep-wake disruption and loss of hypocretin, would therefore be expected to predispose individuals to premature brain aging. Yet available biomarker and neuroimaging findings do not consistently support this possibility, raising questions about the role of hypocretin in mechanisms linking sleep to neurodegeneration. Beyond maintaining wakefulness, hypocretin interacts with inflammatory circuits, metabolic regulation, synaptic plasticity, amyloid processing, and circadian organization. Moreover, wake continuity and neuronal activity during this state may be relevant to the production and release of proteins implicated in neurodegeneration. The coexistence of profound sleep-wake abnormalities and an inconsistent neurodegenerative biomarker profile makes NT1 a unique human condition for investigating these relationships. Understanding this apparent paradox may provide new perspectives on how hypocretin, sleep-wake dynamics, neuronal signaling, and circadian biology relate to long-term brain health and dementia.

PMID:
42826906
Bibliographic data and abstract were imported from PubMed on 03 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.